{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:06:52Z","timestamp":1770484012616,"version":"3.49.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["21173156"],"award-info":[{"award-number":["21173156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2012CB932600"],"award-info":[{"award-number":["2012CB932600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.antiviral.2013.09.006","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T15:32:47Z","timestamp":1379604767000},"page":"356-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations"],"prefix":"10.1016","volume":"100","author":[{"given":"Peichen","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingjun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.09.006_b0005","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1021\/ja0723535","article-title":"Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design","volume":"129","author":"Amaro","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2013.09.006_b0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ncomms1390","article-title":"Mechanism of 150-cavity formation in influenza neuraminidase","volume":"2","author":"Amaro","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2013.09.006_b0015","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1021\/jm800455g","article-title":"A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase","volume":"52","author":"An","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.arcmed.2009.10.007","article-title":"Molecular anatomy of 2009 influenza virus A (H1N1)","volume":"40","author":"Arias","year":"2009","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.antiviral.2013.09.006_b0025","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm0002679","article-title":"BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design","volume":"43","author":"Babu","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/135965350501000805","article-title":"Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment","volume":"10","author":"Barroso","year":"2005","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2013.09.006_b0035","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0040","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0045","series-title":"AMBER","author":"Case","year":"2012"},{"key":"10.1016\/j.antiviral.2013.09.006_b0050","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants","volume":"453","author":"Collins","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.006_b0055","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an W log (N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.antiviral.2013.09.006_b0060","unstructured":"Discovery Studio 2.5 Guide, Accelrys Inc., San Diego, 2009. Available from: http:\/\/www.accelrys.com."},{"key":"10.1016\/j.antiviral.2013.09.006_b0065","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM198209023071002","article-title":"A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection","volume":"307","author":"Dolin","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.09.006_b0070","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2013.09.006_b0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/jm3009713","article-title":"Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors","volume":"56","author":"Feng","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0080","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.1096898","article-title":"Public health risk from the avian H5N1 influenza epidemic","volume":"304","author":"Ferguson","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.09.006_b0085","series-title":"Gaussian 09","author":"Frisch","year":"2009"},{"key":"10.1016\/j.antiviral.2013.09.006_b0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.09.006_b0095","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-2836(03)00610-7","article-title":"Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras\u2013Raf and Ras\u2013RalGDS complexes","volume":"330","author":"Gohlke","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.09.006_b0100","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/JVI.71.5.3385-3390.1997","article-title":"Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en","volume":"71","author":"Gubareva","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.09.006_b0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/318537","article-title":"Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir","volume":"183","author":"Gubareva","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.006_b0110","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2013.09.006_b0115","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1021\/ci100225b","article-title":"Correlation analyses on binding affinity of sialic acid analogues with influenza virus neuraminidase-1 using ab initio MO calculations on their complex structures","volume":"50","author":"Hitaoka","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2013.09.006_b0120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/jm0609162","article-title":"Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance","volume":"50","author":"Hou","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/ci025552a","article-title":"Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies","volume":"43","author":"Hou","year":"2003","journal-title":"J. Chem. Inf. Comp. Sci."},{"key":"10.1016\/j.antiviral.2013.09.006_b0130","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/prot.21808","article-title":"Evaluating the potency of HIV-1 protease drugs to combat resistance","volume":"71","author":"Hou","year":"2008","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.antiviral.2013.09.006_b0135","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jmb.2007.12.054","article-title":"Characterization of domain-peptide interaction interface. A case study on the amphiphysin-1 SH3 domain","volume":"376","author":"Hou","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2013.09.006_b0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1074\/mcp.M800450-MCP200","article-title":"Characterization of domain-peptide interaction interface","volume":"8","author":"Hou","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.antiviral.2013.09.006_b0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. the accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2013.09.006_b0150","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1021\/pr3000688","article-title":"Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein\u2013protein interaction network in yeast by generic structure-based models","volume":"11","author":"Hou","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.antiviral.2013.09.006_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0929-6646(09)60102-9","article-title":"Influenza pandemics: past, present and future","volume":"105","author":"Hsieh","year":"2006","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.antiviral.2013.09.006_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcc.1153","article-title":"Computational alanine scanning of the 1:1 human growth hormone\u2013receptor complex","volume":"23","author":"Huo","year":"2002","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0165","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1021\/jm010338j","article-title":"Molecular dynamics and free energy analyses of cathepsin d-inhibitor interactions: insight into structure-based ligand design","volume":"45","author":"Huo","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0170","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/AAC.00334-09","article-title":"In vitro generation of neuraminidase inhibitor resistance in A (H5N1) influenza viruses","volume":"53","author":"Hurt","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.006_b0175","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.antiviral.2013.09.006_b0180","first-page":"1","article-title":"Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach","author":"Karthick","year":"2012","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.antiviral.2013.09.006_b0185","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.antiviral.2013.09.006_b0190","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.antiviral.2013.09.006_b0195","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1021\/jm000241h","article-title":"Binding of a diverse set of ligands to avidin and streptavidin: An accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models","volume":"43","author":"Kuhn","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0200","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1021\/jm049081q","article-title":"Validation and use of the MM-PBSA approach for drug discovery","volume":"48","author":"Kuhn","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0205","first-page":"13","article-title":"Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe","author":"Lackenby","year":"2008","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2013.09.006_b0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1747-0285.2007.00614.x","article-title":"Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble","volume":"71","author":"Landon","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.antiviral.2013.09.006_b0215","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1021\/ct200230v","article-title":"Effects of biomolecular flexibility on alchemical calculations of absolute binding free energies","volume":"7","author":"Lawrenz","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.antiviral.2013.09.006_b0220","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/4371108a","article-title":"Avian flu: isolation of drug-resistant H5N1 virus","volume":"437","author":"Le","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.006_b0225","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/ci300375k","article-title":"Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A\/H1N1 influenza neuraminidase","volume":"52","author":"Li","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2013.09.006_b0230","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/mp100041b","article-title":"In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase","volume":"7","author":"Liu","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.antiviral.2013.09.006_b0235","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/prot.21897","article-title":"Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1","volume":"71","author":"Malaisree","year":"2008","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.antiviral.2013.09.006_b0240","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1021\/jm030060q","article-title":"Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations","volume":"46","author":"Masukawa","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(00)00103-0","article-title":"Resistance of influenza viruses to neuraminidase inhibitors\u2014a review","volume":"47","author":"McKimm-Breschkin","year":"2000","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.006_b0250","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/AAC.49.11.4515-4520.2005","article-title":"Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors","volume":"49","author":"Mishin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.09.006_b0255","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/clinids\/15.2.362","article-title":"Implications of viral resistance to amantadine in control of influenza A","volume":"15","author":"Monto","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.006_b0260","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.09.006_b0265","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance\u2014disabling our influenza defenses","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.09.006_b0270","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nature08157","article-title":"Emergence and pandemic potential of swine-origin H1N1 influenza virus","volume":"459","author":"Neumann","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.006_b0275","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/ci2000743","article-title":"Study of Tamiflu sensitivity to variants of A\/H5N1 virus using different force fields","volume":"51","author":"Nguyen","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2013.09.006_b0280","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/jp994072s","article-title":"Modification of the generalized Born model suitable for macromolecules","volume":"104","author":"Onufriev","year":"2000","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0285","first-page":"585","article-title":"A revision of the system of nomenclature for influenza viruses: a WHO memorandum. B","volume":"58","author":"Organization","year":"1980","journal-title":"World Health Organ."},{"key":"10.1016\/j.antiviral.2013.09.006_b0290","series-title":"Clinical features of severe cases of pandemic influenza Pandemic (H1N1) 2009 briefing note 13","author":"Organization","year":"2009"},{"key":"10.1016\/j.antiviral.2013.09.006_b0295","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/nm1141","article-title":"Influenza: old and new threats","volume":"10","author":"Palese","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2013.09.006_b0300","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1021\/ci900348n","article-title":"Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir","volume":"49","author":"Park","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2013.09.006_b0305","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1074\/jbc.R500020200","article-title":"The M2 proton channels of influenza A and B viruses","volume":"281","author":"Pinto","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0310","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/jiq010","article-title":"Generation and characterization of recombinant pandemic influenza A (H1N1) viruses resistant to neuraminidase inhibitors","volume":"203","author":"Pizzorno","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2013.09.006_b0315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bpc.2009.08.006","article-title":"How does each substituent functional group of oseltamivir lose its activity against virulent H5N1 influenza mutants?","volume":"145","author":"Rungrotmongkol","year":"2009","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0320","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature05114","article-title":"The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design","volume":"443","author":"Russell","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2013.09.006_b0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of <i> n<\/i>-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.antiviral.2013.09.006_b0330","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jac\/44.1.6","article-title":"Chemotherapeutic control of influenza","volume":"44","author":"Stephenson","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.09.006_b0335","doi-asserted-by":"crossref","first-page":"14610","DOI":"10.1073\/pnas.2235620100","article-title":"Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion","volume":"100","author":"Takeda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.09.006_b0340","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1073\/pnas.1116200109","article-title":"A distinct lineage of influenza A virus from bats","volume":"109","author":"Tong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2013.09.006_b0345","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1021\/ci900277r","article-title":"Dynamic Behavior of Avian Influenza A Virus Neuraminidase Subtype H5N1 in Complex with Oseltamivir, Zanamivir, Peramivir, and Their Phosphonate Analogues","volume":"49","author":"Udommaneethanakit","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2013.09.006_b0350","doi-asserted-by":"crossref","first-page":"e1002249","DOI":"10.1371\/journal.ppat.1002249","article-title":"Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition","volume":"7","author":"Vavricka","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.09.006_b0355","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrd2400","article-title":"The war against influenza: discovery and development of sialidase inhibitors","volume":"6","author":"Von Itzstein","year":"2007","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.antiviral.2013.09.006_b0360","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/protein\/gzp055","article-title":"Computational studies of H5N1 influenza virus resistance to oseltamivir","volume":"18","author":"Wang","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2013.09.006_b0365","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0370","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/157340906778226454","article-title":"Recent advances in free energy calculations with a combination of molecular mechanics and continuum models","volume":"2","author":"Wang","year":"2006","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.antiviral.2013.09.006_b0375","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMp068205","article-title":"H5N1 influenza\u2014continuing evolution and spread","volume":"355","author":"Webster","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.09.006_b0380","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","article-title":"Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)","volume":"20","author":"Weiser","year":"1999","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2013.09.006_b0385","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1021\/bi300561n","article-title":"Long time scale gpu dynamics reveal the mechanism of drug resistance of the dual mutant I223R\/H275Y neuraminidase from H1N1-2009 influenza virus","volume":"51","author":"Woods","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2013.09.006_b0390","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1021\/jp404160y","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 3. The impact of force fields and ligand charge models","volume":"117","author":"Xu","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.antiviral.2013.09.006_b0395","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.antiviral.2011.11.007","article-title":"Molecular modeling study on the resistance mechanism of HCV NS3\/4A serine protease mutants R155K, A156V and D168A to TMC435","volume":"93","author":"Xue","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.09.006_b0400","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/ci100427j","article-title":"Molecular dynamics simulation, free energy calcuiation and structure-based 3D-QSAR studies of B-RAF kinase inhibitors","volume":"51","author":"Yang","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.antiviral.2013.09.006_b0405","series-title":"Pandemic influenza as a current threat","author":"Yen","year":"2009"},{"key":"10.1016\/j.antiviral.2013.09.006_b0410","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1073\/pnas.0907304107","article-title":"Detecting and understanding combinatorial mutation patterns responsible for HIV drug resistance","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:59:31Z","timestamp":1715990371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213002520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0166354213002520"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.006","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}